1. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America
2. British Thoracic Association. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy.Am Rev Respir Dis1982;126:460–462.
3. Five-Year Follow-Up of a Controlled Trial of Five 6-Month Regimens of Chemotherapy for Pulmonary Tuberculosis
4. Tam CM, Chan SL, Kam KM, Goodall RL, Mitchison DA. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.Int J Tuberc Lung Dis2002;6:3–10.
5. Aber VR, Nunn AJ. Factors affecting relapse following short-course chemotherapy.Bull Int Union Tuberc1978;53:276–280.